In order to combat shortages of Epipen (epinephrine), Health Canada has issued an interim order allowing the immediate importation of the epinephrine auto-injector AUVI-Q® manufactured in the USA and approved by the Food and Drug Administration (FDA). Importantly, AUVI-Q®is not licensed for use in Canada.
Interim orders are a method of access to unlicensed medicines and can be made when immediate action is necessary to deal with a significant risk to health, safety or the environment. Interim orders have been used in the past to address drug shortages, notably for influenza vaccines between 2009-2010 and for naloxone spray in 2016 for the emergency treatment of drug overdose.
The interim order can be viewed here.